BMA Biomedicals

BMA Biomedicals is a small biotech company, founded in 1989 in the Basel area in northern Switzerland. Its main area of activity is in the development, manufacturing and marketing of antibodies.

BMA's knowledge and expertise focuses on the application of antibodies in immunohistochemistry and enzyme immunoassays. Even though the products are manufactured and sold for in vitro research use only, the licensing of successful products to companies which are active in medical diagnostics is supported. This applies particularly to our top-selling Calprotectin reagents and ELISAs.

BMA Biomedicals has its own modern research and development facilities and can carry out contractual research for scientific or industrial institutions. Our know-how lies in the development, production and derivatization of monoclonal and polyclonal antibodies, and their use in immunological techniques. BMA also acquires products which are in line with internal activities. These products may be in early development stages and are finally updated for manufacture by the company.

The product range of BMA Biomedicals is customer oriented and includes many products that focus on a limited and specialized group of customers. We have established longstanding and excellent working relationships with distributors and customers worldwide.

Showing 0 of 0 results